Trovagene

Trovagene is a precision medical biotechnology company that develops oncology therapeutics to improve cancer treatment by leveraging its proprietary Precision Cancer Monitoring® (PCM) technology in the field of tumor genomics. Trovagene has extensive intellectual property and proprietary technologies for measuring circulating tumor DNA (ctDNA) in urine and blood to identify and quantify clinically actionable markers for predicting responses to cancer therapies.